Clinical trials
Observational Arthritis, Rheumatoid trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 7 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 9 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Active, not recruiting | 9 |
| Recruiting | 5 |
| Terminated | 3 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 8 |
| Zimmer Biomet | 7 |
| Aesculap AG | 6 |
| Bristol-Myers Squibb | 4 |
| MicroPort Orthopedics Inc. | 4 |
| Pfizer | 4 |
| AbbVie | 3 |
| Biogen | 3 |
| AbbVie (prior sponsor, Abbott) | 2 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 65 |
| Osteoarthritis | 18 |
| Osteonecrosis | 10 |
| Joint Diseases | 8 |
| Ankylosis | 5 |
| Arthritis, Psoriatic | 5 |
| Spondylitis, Ankylosing | 5 |
| Arthritis | 4 |
| Axial Spondyloarthritis | 4 |
| Hip Fractures | 3 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.